Anti-VEGF/VPF Treatment Suppresses the Growth of PEL Cells in SCID/beige Mice
| Treatment . | No. of Mice Injected . | No. of Mice With Malignant Effusion . |
|---|---|---|
| PBS | 8 | 7 (88%) |
| Antihuman VEGF/VPF Ab | 9 | 0 (0%) |
| Isotype control Ab | 6 | 6 (100%) |
| Treatment . | No. of Mice Injected . | No. of Mice With Malignant Effusion . |
|---|---|---|
| PBS | 8 | 7 (88%) |
| Antihuman VEGF/VPF Ab | 9 | 0 (0%) |
| Isotype control Ab | 6 | 6 (100%) |
Groups of mice were injected IP with BCBL-1 cells (1 × 107 cells/mouse) 1 day after γ-irradiation (400 rad). Mice received IP injections of PBS, antihuman VEGF/VPF Ab, or isotype control Ab twice weekly. Mice were killed 30 days later.